![Daiichi Sankyo Co Ltd](/common/images/company/TG_D4S.png)
A life-extending drug for incurable breast cancer will not be made available on the health service in England after i ...
Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotama ...
Daiichi Sankyo Co Ltd on Wednesday said that strong sales of its flagship medicines drove revenue growth in its lates ...
AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved t ...
escription of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria) (Alliance News ...
AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US. The Cambri ...
A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a ...
AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketin ...
AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc. The Cambridge-based pharmaceutical ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.